Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma.
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2014
At a glance
- Drugs Calcitriol (Primary) ; Diclofenac (Primary)
- Indications Basal cell cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 24 Apr 2013 Planned end date changed from 1 Nov 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 24 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.